Clinical Trial Update: Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 randomized, double-blind, placebo-controlled study to evaluate safety and pharmacokinetics of MEDI3902 in healthy adults; results posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Aeruginosa Pneumonia Prevention

Drugs mentioned

• MEDI3902 (MEDI3902)

Snippet

Sponsor: MedImmune LLC | Conditions: MEDI3902 for Prevention of P. Aeruginosa Pneumonia | Phase 1 | Status: COMPLETED | Results posted: 2018-08-13